Table 1. Details of 13 patients with orbital liposarcoma.
| No. | Age (y) | Sex | Affected orbital side | Disease course (mo) | Disease status | Clinical manifestations | Visual acuity | Operative treatment | Follow-up treatment | Relations between liposarcoma with surrounding tissue | Longest diameter of liposarcoma (cm) | Histological subtype | Immunohistochemical indicators |
||||
| Ki-67 | Vimentin | CD34 | SMA | S-100 | |||||||||||||
| 1 | 51 | F | OS | 1 | Primary | Eyelid palpable mass | 1 | Tumor resection | Radioactive seed implantation | Orbital bone | 1.8 | Myxiod | 60% | + | + | + | + |
| 2 | 44 | M | OD | 16 | Primary | Eyelid palpable mass | 5.1 | Orbital exenteration | External gamma radiation therapy | Optic nerve | 6 | Dedifferentiated | 1% | + | + | - | + |
| 3 | 81 | M | OS | 12 | Primary | Proptosis & diplopia | 4.9 | Tumor resection | Radioactive seed implantation | / | 2.8 | Myxiod | / | / | / | / | / |
| 4 | 36 | F | OD | 2 | Primary | Proptosis | 4.85 | Tumor resection | External gamma radiation therapy | / | 5 | Pleomorphic | 70% | + | + | - | + |
| 5 | 61 | F | OS | 10 | Primary | Proptosis & epiphora | 4.9 | Tumor resection | External gamma radiation therapy | / | 2.8 | Well-differentiated | 1% | + | + | / | + |
| 6 | 19 | F | OD | 12 | Primary | Proptosis | 5 | Tumor resection | / | Striated muscle | / | Myxiod | 3% | + | - | - | + |
| 7 | 24 | F | OD | 36 | Primary | Proptosis | 4.8 | Tumor resection | No follow-up treatment | Striated muscle | / | Dedifferentiated | 100% | / | + | + | + |
| 8 | 63 | M | OS | 12 | Primary | Proptosis | 4.7 | Orbital exenteration | No follow-up treatment | Optic nerve | 3.5 | Myxiod | 5% | + | / | - | + |
| 9 | 36 | F | OD | 9 | Primary | Proptosis | 3.8 | Orbital exenteration | External gamma radiation therapy | Optic nerve | 4 | Well-differentiated | 5% | + | + | - | - |
| 10 | 57 | F | OD | 24 | Primary | Proptosis & diplopia | 3 | Tumor resection | No follow-up treatment | Striated muscle | 2 | Dedifferentiated | 3% | + | + | + | + |
| 11 | 34 | M | OD | 1 | Primary | Proptosis | 4.85 | Tumor resection | External gamma radiation therapy | Orbital bone | 4 | Myxiod | 40% | + | - | - | + |
| 12 | 50 | M | OS | 8 | Secondary | Proptosis | 3.5 | Tumor resection | / | Striated muscle | / | Myxiod | / | / | / | + | - |
| 13 | 32 | F | OD | 6 | Primary | Proptosis | 3.3 | Tumor resection | External gamma radiation therapy | Striated muscle | 3.5 | Well-differentiated | 20% | / | + | — | - |
OD: Right eye; OS: Left eye; SMA: Smooth muscle actin.